Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-5 of 5
Keywords: Survival
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Stereotact Funct Neurosurg (2021) 99 (3): 181–186.
Published Online: 23 March 2021
... months after GKRS, 25.0% at 6 months, and 7.1% at 12 months. The mean and median progression-free survival (PFS) periods were 8.6 (95% CI, 6.3–11.0) and 4 (95% CI, 3.5–4.5) (range, 1–60) months, respectively. The overall survival (OS) after GKRS was 3–62 months, with a mean of 16.7 (95% CI, 14.6–18.9...
Journal Articles
Sang Ryul Lee, Tae Hoon Roh, Dong Hwan Jeong, Namkyu You, Ae Hwa Jang, Mi Ra Seo, Jin Hee Choung, Bumhee Park, Se-Hyuk Kim
Stereotact Funct Neurosurg (2020) 98 (4): 278–285.
Published Online: 14 May 2020
... scoring system for the prediction of survival time. Methods: We retrospectively analyzed data for 311 patients treated with Gamma Knife radiosurgery at a single institute. The mean age at time of treatment was 60 years (range 23–86 years), and the median Karnofsky performance status (KPS) score was 90...
Journal Articles
Stereotact Funct Neurosurg (2019) 97 (2): 94–100.
Published Online: 22 May 2019
... survival duration was 21.1 months for all patients. Median tumor volume was 14.3 cm 3 (range, 10.0–58.3 cm 3 ). The local control rate was 77.0% and the progression-free survival rate was 73.6% at the last follow-up. There were no significant between-group differences in terms of local control rate ( p...
Journal Articles
Ashwin A. Kamath, Daniel D. Friedman, Carl D. Hacker, Matthew D. Smyth, David D. Limbrick Jr., Albert H. Kim, Ammar H. Hawasli, Eric C. Leuthardt
Stereotact Funct Neurosurg (2018) 95 (6): 417–428.
Published Online: 17 January 2018
... rate of complication ( p = 0.056). Median progression-free survival (PFS) and overall survival (OS) for recurrent GBM were 7.4 and 11.6 months, respectively. As a frontline treatment for newly diagnosed GBM, median PFS and OS were 5.9 and 11.4 months, respectively. For metastases, median PFS...
Journal Articles
Stereotact Funct Neurosurg (2003) 78 (2): 70–83.
Published Online: 29 January 2003
... neurosurgical craniotomy (NS; 130 patients), whole-brain radiotherapy (WBRT; 120 patients). Linac XKnife radiosurgery (RS; 130 patients) and Linac XKnife radiosurgery plus WBRT (RT; 83 cases). Survival was measured from the time of treatment and was analyzed by the Kaplan-Meier product-limit method...